Published in Ann R Coll Surg Engl on January 01, 2015
Effects of Intravenous and Catheter Directed Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator (Alteplase) in Non-Traumatic Acute Limb Ischemia; A Randomized Double-Blind Clinical Trial. Bull Emerg Trauma (2015) 0.80
Trends in hospital admissions and surgical procedures for degenerative lumbar spine disease in England: a 15-year time-series study. BMJ Open (2015) 0.76
Management Strategy in Non-Limb-Threatening Acute Ischaemia of Limbs: Should We Rethink? Case Rep Vasc Med (2016) 0.75
Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet (2005) 5.38
A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med (1998) 3.58
Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA (2006) 3.50
Systematic review of discharge coding accuracy. J Public Health (Oxf) (2011) 2.88
Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ (2012) 2.73
Explaining the decrease in mortality from abdominal aortic aneurysm rupture. Br J Surg (2012) 2.01
Is the incidence of abdominal aortic aneurysm declining in the 21st century? Mortality and hospital admissions for England & Wales and Scotland. Eur J Vasc Endovasc Surg (2011) 1.65
Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg (1994) 1.62
Twenty-year analysis of trends in the incidence and in-hospital mortality for lower-extremity arterial thromboembolism. Circulation (2013) 1.49
A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann Surg (2003) 1.10
Management of acute leg ischaemia in the elderly. Br J Surg (1998) 1.00
Lower limb amputations in Southern Finland in 2000 and trends up to 2001. Eur J Vasc Endovasc Surg (2004) 0.98
National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): clinical factors associated with early outcome. J Vasc Surg (2004) 0.95
Incidence of descending aortic pathology and evaluation of the impact of thoracic endovascular aortic repair: a population-based study in England and Wales from 1999 to 2010. Eur J Vasc Endovasc Surg (2012) 0.92
Time trends in incidence rates of acute, non-traumatic extremity ischaemia: a population-based study during a 19-year period. Br J Surg (1991) 0.82
Atrial fibrillation: improvement in identification and stroke preventive therapy - data from the UK Clinical Practice Research Datalink, 2000-2012. Int J Cardiol (2013) 0.82
Atrial fibrillation as a cause of death increased steeply in England between 1995 and 2010. Europace (2013) 0.81
Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (1995) 3.00
Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med (2002) 2.73
Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Endovasc Surg (2011) 2.69
Arterial bypass surgery and smokers. BMJ (1994) 2.32
Mechanical properties of the aneurysmal aorta. Br J Surg (1992) 2.29
Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation (2001) 2.29
Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Ann Surg (1999) 2.27
Causes of re-recurrence after polytetrafluoroethylene patch saphenoplasty for recurrent varicose veins. Br J Surg (2000) 2.15
Explaining the decrease in mortality from abdominal aortic aneurysm rupture. Br J Surg (2012) 2.01
The Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM). Br J Surg (2003) 1.93
Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg (2005) 1.90
Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol (2004) 1.84
Population screening reduces mortality rate from aortic aneurysm in men. Br J Surg (2000) 1.79
The endovascular revolution. Ann R Coll Surg Engl (1997) 1.73
Ultrasound measurement of aortic diameter in a national screening programme. Eur J Vasc Endovasc Surg (2011) 1.68
Is the incidence of abdominal aortic aneurysm declining in the 21st century? Mortality and hospital admissions for England & Wales and Scotland. Eur J Vasc Endovasc Surg (2011) 1.65
The management of short saphenous varicose veins: a survey of the members of the vascular surgical society of Great Britain and Ireland. Eur J Vasc Endovasc Surg (2004) 1.63
Review of the management of recurrent inguinal hernia. Hernia (2003) 1.60
Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. BMJ (1989) 1.60
Abdominal aortic aneurysm: the prognosis in women is worse than in men. Circulation (2007) 1.59
Prevention of incisional hernia after aortic aneurysm repair. Eur J Vasc Endovasc Surg (2003) 1.57
Recombinant tissue-type plasminogen activator is superior to streptokinase for local intra-arterial thrombolysis. Br J Surg (1992) 1.55
A 5-year review of carotid endarterectomy in a vascular unit using a computerised audit system. Ann R Coll Surg Engl (1992) 1.53
Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg (2012) 1.50
The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy. Health Technol Assess (2012) 1.49
Long-term cost-effectiveness analysis of endovascular versus open repair for abdominal aortic aneurysm based on four randomized clinical trials. Br J Surg (2014) 1.48
Stripping the long saphenous vein reduces the rate of reoperation for recurrent varicose veins: five-year results of a randomized trial. J Vasc Surg (1999) 1.46
Vitamin D and cardiovascular disease. Circ Res (2014) 1.46
Reprinted article "Neovascularisation is the principal cause of varicose vein recurrence: results of a randomised trial of stripping the long saphenous vein". Eur J Vasc Endovasc Surg (2011) 1.42
The purification and properties of the aspartate aminotransferase and aromatic-amino-acid aminotransferase from Escherichia coli. Eur J Biochem (1978) 1.41
111In-labelled leucocyte imaging in vascular graft infection. Br J Surg (1989) 1.39
Slowing the heart saves lives: advantages of perioperative beta-blockade. Br J Surg (2000) 1.39
Peripheral thrombolysis for acute-onset claudication. Thrombolysis Study Group. Br J Surg (1999) 1.38
Limitations of ultrasonography in surveillance of small abdominal aortic aneurysms. Br J Surg (1991) 1.35
The nature of stacking equilibria in polynucleotides. Biopolymers (1972) 1.33
Purification and properties of lung lectin. Rat lung and human lung beta-galactoside-binding proteins. Biochem J (1980) 1.31
Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation (1999) 1.30
High prevalence of unsuspected abdominal aortic aneurysm in patients with confirmed symptomatic peripheral or cerebral arterial disease. Br J Surg (1993) 1.26
Modification of surface composition of Actinomyces viscosus T14V and T14AV. Infect Immun (1978) 1.25
Neovascularisation is the principal cause of varicose vein recurrence: results of a randomised trial of stripping the long saphenous vein. Eur J Vasc Endovasc Surg (1996) 1.23
Collagen in abdominal aortic aneurysm: typing, content, and degradation. J Vasc Surg (1987) 1.21
Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial. On behalf of the UK Small Aneurysm Trial participants. Br J Surg (2000) 1.21
A comparison of reports from referees chosen by authors or journal editors in the peer review process. Ann R Coll Surg Engl (2000) 1.17
Elastin degradation in abdominal aortic aneurysms. Atherosclerosis (1987) 1.16
Observations from the IMPROVE trial concerning the clinical care of patients with ruptured abdominal aortic aneurysm. Br J Surg (2014) 1.16
Aortic aneurysm diameter and risk of cardiovascular mortality. Arterioscler Thromb Vasc Biol (2001) 1.15
Postnatal development of rat lung. Changes in lung lectin, elastin, acetylcholinesterase and other enzymes. Biochem J (1980) 1.14
Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm. Br J Surg (2008) 1.13
Cutting the cost of emergency surgical admissions. Ann R Coll Surg Engl (1996) 1.12
Acute non-traumatic arm ischaemia. Br J Surg (1998) 1.10
Site specificity of aneurysmal disease. Circulation (2010) 1.10
A single normal ultrasonographic scan at age 65 years rules out significant aneurysm disease for life in men. Br J Surg (2001) 1.10
Smoking impairs endothelium-dependent relaxation of saphenous vein. Br J Surg (1993) 1.10
Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol (1998) 1.09
A comparison of the mortality rate after elective repair of aortic aneurysms detected either by screening or incidentally. Eur J Vasc Endovasc Surg (2000) 1.09
Affinity labeling of bovine colostrum galactosyltransferase with a uridine 5'-diphosphate derivative. Biochemistry (1976) 1.09
Multiple antibiotic resistance in clinical strains of Neisseria gonorrhoeae isolated in South Carolina. Antimicrob Agents Chemother (1976) 1.09
Pathogenesis of abdominal aortic aneurysm. Br J Surg (1994) 1.09
Part two: Against the motion. External diameter for AAA size. Eur J Vasc Endovasc Surg (2013) 1.07
A model for national outcome audit in vascular surgery. Eur J Vasc Endovasc Surg (2001) 1.06
The UK Endovascular Aneurysm Repair (EVAR) trials: design, methodology and progress. Eur J Vasc Endovasc Surg (2004) 1.06
Cadmium accumulation in aortas of smokers. Arterioscler Thromb Vasc Biol (2001) 1.05
Comparison of POSSUM scoring and the Hardman Index in selection of patients for repair of ruptured abdominal aortic aneurysm. Br J Surg (2003) 1.03
Intraoperative use of thrombolytic agents. BMJ (1993) 1.01
Randomized clinical trial of compression plus surgery versus compression alone in chronic venous ulceration (ESCHAR study)--haemodynamic and anatomical changes. Br J Surg (2005) 1.01
Metalloproteinases in degenerative aortic disease. Clin Sci (Lond) (1991) 1.01
Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness. Health Technol Assess (2013) 1.01
Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells. Arterioscler Thromb Vasc Biol (2000) 1.01
Oxidation and chemical modification of lung beta-galactoside-specific lectin. Biochem J (1986) 1.00
Management of acute leg ischaemia in the elderly. Br J Surg (1998) 1.00
Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol (1996) 1.00
Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg (2007) 0.99
Glycosyltransferases in the Golgi membranes of onion stem. Biochem J (1974) 0.98
Early results of low dose intra-arterial streptokinase therapy in acute and subacute lower limb arterial ischaemia. Br J Surg (1987) 0.97
Influence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysm in rabbits. Arterioscler Thromb Vasc Biol (1997) 0.96
Smoking and growth rate of small abdominal aortic aneurysms. Lancet (1994) 0.96
Randomized clinical trial of mesh versus sutured wound closure after open abdominal aortic aneurysm surgery. Br J Surg (2010) 0.95
Are cerebral aneurysms atherosclerotic? Stroke (1994) 0.95
Metal ion activation of galactosyltransferase. J Biol Chem (1976) 0.95
Prostaglandin E2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells. J Vasc Surg (2003) 0.95
The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland. Eur J Vasc Endovasc Surg (2007) 0.94
Arterial embolectomy: a century and out. Br J Surg (1994) 0.94
Patient fitness and survival after abdominal aortic aneurysm repair in patients from the UK EVAR trials. Br J Surg (2007) 0.94
Acute leg ischaemia in Gloucestershire. Br J Surg (1997) 0.93
Recommendations for screening intervals for small aortic aneurysms. Br J Surg (2003) 0.93
Role of the Escherichia coli aromatic amino acid aminotransferase in leucine biosynthesis. J Bacteriol (1978) 0.93
Genotype-phenotype relationships in an investigation of the role of proteases in abdominal aortic aneurysm expansion. Br J Surg (2005) 0.93
Clinicopathological evidence that neovascularisation is a cause of recurrent varicose veins. Eur J Vasc Endovasc Surg (1998) 0.93
Comparison of different methods of risk stratification in urgent and emergency surgery. Br J Surg (2007) 0.92
Enzymic characteristics of fat globule membranes from bovine colostrum and bovine milk. J Cell Biol (1977) 0.92
Incidence of descending aortic pathology and evaluation of the impact of thoracic endovascular aortic repair: a population-based study in England and Wales from 1999 to 2010. Eur J Vasc Endovasc Surg (2012) 0.92
Management of primary and recurrent inguinal hernia by surgeons from the South West of England. Ann R Coll Surg Engl (2003) 0.91
Mechanism of late prosthetic vascular graft infection. Cardiovasc Surg (1997) 0.91
The influence of smoking and lipids on restenosis after carotid endarterectomy. Eur J Vasc Surg (1993) 0.90
Vasoactive effects of fibrinogen on saphenous vein. Nature (1996) 0.90
Arterial flow conditions downregulate thrombomodulin on saphenous vein endothelium. Circulation (1999) 0.90
Unrestricted usage of immunoglobulin heavy chain genes in B cells infiltrating the wall of atherosclerotic abdominal aortic aneurysms. Atherosclerosis (1997) 0.90
Identifying high-risk patients undergoing urgent and emergency surgery. Ann R Coll Surg Engl (2006) 0.89